Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
1.530
-0.090 (-5.56%)
At close: Sep 30, 2026, 4:00 PM EDT
1.520
-0.010 (-0.65%)
Pre-market: Oct 1, 2026, 5:55 AM EDT
Firefly Neuroscience Revenue
Firefly Neuroscience had revenue of $514.00K in the quarter ending June 30, 2026, with 71.91% growth. This brings the company's revenue in the last twelve months to $1.80M, up 320.33% year-over-year. In the year 2025, Firefly Neuroscience had annual revenue of $1.14M with 957.41% growth.
Revenue (ttm)
$1.80M
Revenue Growth
+320.33%
P/S Ratio
13.34
Revenue / Employee
$105,824
Employees
17
Market Cap
24.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.14M | 1.03M | 957.41% |
| Dec 31, 2024 | 108.00K | -390.00K | -78.31% |
| Dec 31, 2023 | 498.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 6.86M | 148.57K | 2.21% |
| Dec 31, 2009 | 6.71M | 17.92K | 0.27% |
| Dec 31, 2008 | 6.69M | -3.26M | -32.75% |
| Dec 31, 2007 | 9.95M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Creative Realities | 72.32M |
| NextPlat | 48.89M |
| Intelligent Protection Management | 25.19M |
| MIND C.T.I. | 19.41M |
| VirTra | 17.50M |
| Aware | 16.43M |
| Intellinetics | 16.18M |
| Future FinTech Group | 3.24M |
AIFF News
- 5 days ago - Firefly, NeuroSigma partner to expand awareness, access to Monarch eTNS - TheFly
- 5 days ago - Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD - GlobeNewsWire
- 13 days ago - Firefly Neuroscience's Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial's AI-Native Operating System for Brain Medicine - GlobeNewsWire
- 1 month ago - Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes - GlobeNewsWire
- 2 months ago - Firefly Neuroscience partners with Next Health on cognitive health platform - TheFly
- 2 months ago - Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee's Recommendation Backs Broader Access to Key Neuroprotective Peptides - GlobeNewsWire
- 4 months ago - Firefly's AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD - GlobeNewsWire
- 4 months ago - Firefly Neuroscience files to sell 22.5M shares of common stock for holders - TheFly